Opendata, web and dolomites


Lab-on-Skin: A wearable medical device for improved clinical trial monitoring

Total Cost €


EC-Contrib. €






Project "Lab-on-Skin" data sheet

The following table provides information about the project.


Organization address
postcode: 1015
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-10-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    XSENSIO SA CH (LAUSANNE) coordinator 50˙000.00


 Project objective

The high costs and long timelines associated with drug development are a major burden to society. The healthcare industry is increasingly looking for systems and processes to reduce the costs of developing and testing new drugs. Commercial wearable medical devices have recently found their ways into clinical trials, with pharma companies looking for new tools to monitor patients enrolled in clinical trials. Although such wearables can track a plethora of patient parameters and offer advantages that stand to improve the way in which clinical trials are designed and conducted, they only measure physical parameters of patients and fail to measure biochemical parameters that are directly relevant to drug development (biomarkers). Xsensio has leveraged the most advanced innovations from the fields of nanotechnology, biochemistry, and microfluidics to develop its proprietary Lab-on-Skin™ platform. At its core, the Lab-on-Skin™ platform contains an innovative functionalized sensor chip that is capable of measuring biomarkers in sweat. With the remote, continuous, and real-time monitoring of biomarkers, ultra-low power consumption, and optimized design for mass-production, the Lab-on-Skin™ platform is highly attractive for integration into wearable devices for 24/7 monitoring of patients. In this project, Xsensio will perform a feasibility study to (1) select a panel of biomarkers that maximize the (clinical) applications of the Lab-on-Skin™ platform, (2) obtain quantitative and qualitative market data, (3) construct roadmaps for navigating the regulatory landscape, (4) strengthen and expand its current IP position, and (5) consolidate all current and future findings into a business plan.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LAB-ON-SKIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LAB-ON-SKIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

GREEN WHS (2019)


Read More  

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

SQP (2019)

Opening new markets for Single Quantum Photodetectors

Read More